Stocks & Financial News
Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts
Syros to Participate in Upcoming Investor Conferences
JMP Securities 2024 Life Sciences Conference Date: Tuesday, May 14 Presentation Time: 11:00 a.m. ET Location: New York Hilton Midtown, 1335 Sixth Avenue, New York, NY
TD Cowen's 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA Date: Wednesday, May 29 Presentation Time: 1:00 p.m. ET Location: Virtual
To access the webcasts and subsequent archived recording of each event, please visit the Investors & Media section of the Syros website at www.syros.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARa agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240507063235/en/
SOURCE: Syros Pharmaceuticals
<img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240507063235r1&sid=cmtx6&distro=nx&lang=en" style="width:0;height:0" />
Syros Contact Karen Hunady Director of Corporate Communications & Investor Relations 1-857-327-7321 khunady@syros.com Investor Contact Amanda Isacoff Stern Investor Relations, Inc. 212-362-1200 amanda.isacoff@sternir.com
COMTEX_452008964/1006/2024-05-07T09:00:02